// App-Quantinova.ai

1106 : Safety and Efficacy of Direct Acting Antivirals: UK Real World Experience from a Large Well Characterised Predominantly Cirrhotic HCV Cohort

Researchers

Presenter

  • Lucia Macken

Principal Investigators

  • Sumita Verma

  • Graham R. Foster

  • John McLauchlan

  • William Irving

Medical Centers

  • Hepatology/Medicine, Brighton and Sussex Medical School, Brighton and Sussex University Hospitals NHS Trust, Brighton, United Kingdom

  • Queen Mary University of London, London, United Kingdom

  • University of Glasgow, Glasgow, United Kingdom

  • University of Nottingham, Nottingham, United Kingdom

  • HCV Research UK, Nottingham, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved